A kind of almotriptan tablet and preparation method thereof
A technology of almotriptan tablet and almotriptan, which is applied in directions such as pill delivery, pharmaceutical formulations, and non-active ingredient medical preparations, can solve the problems of unfavorable drug efficacy, low dissolution rate of main drug, etc., and achieves dissolution good effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The preparation of embodiment 1 tablet of the present invention
[0026] prescription:
[0027]
[0028] Preparation:
[0029] Pass the raw materials through a 100-mesh sieve and the auxiliary materials through a 80-mesh sieve. Mix the raw materials, mannitol, microcrystalline cellulose, and 50% sodium carboxymethyl starch successively, add 10% povidone K30 aqueous solution to make a soft material, granulate with a 20-mesh sieve, and dry at 60°C , 20-mesh sieve for granulation, add the remaining sodium carboxymethyl starch and magnesium stearate from the excipients, mix evenly, and compress into tablets.
Embodiment 2
[0030] The preparation of embodiment 2 tablet of the present invention
[0031] prescription:
[0032]
[0033] Preparation:
[0034] Pass the raw materials through a 100-mesh sieve and the auxiliary materials through a 80-mesh sieve. Mix the raw materials and the internally added auxiliary materials sodium carboxymethyl starch, mannitol, and microcrystalline cellulose in sequence, add 10% povidone K30 aqueous solution to make a soft material, granulate with a 20-mesh sieve, and dry at 60°C. Sieve through a 20-mesh sieve, add magnesium stearate as an excipient, mix evenly, and compress into tablets.
Embodiment 3
[0035] The investigation of embodiment 3 tablet auxiliary material of the present invention
[0036] 1. Quality screening of molded tablets
[0037] Tablets are prepared according to the prescription shown in Table 1, and the quality of the tablets is detected, thereby screening out the best conditions of the present invention, and the detection results are shown in Table 2.
[0038] Prescription 1~9 preparation process:
[0039] Pass the raw materials through a 100-mesh sieve and the auxiliary materials through a 80-mesh sieve. Mix the raw materials and the internally added auxiliary materials sodium carboxymethyl starch, mannitol, and microcrystalline cellulose in sequence, add 10% povidone K30 aqueous solution to make a soft material, granulate with a 20-mesh sieve, and dry at 60°C. Sieve through a 20-mesh sieve, add magnesium stearate as an excipient, mix evenly, and compress into tablets.
[0040] Prescription 10 preparation process:
[0041] Pass the raw materials th...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 